The animal investigation demonstrated that berberine administration substantially decreased the formation of 4-hydroxy 2-nonenal (4-HNE) adducts while elevating levels of both insulin and insulin receptors in the hippocampus, indicating improved insulin uptake and signaling within the brain tissue of the treated diabetic rodents.
Berberine, a component of the Chinese herb, is used for treating diabetes and diabetes-associated cognitive dysfunction, although the underlying mechanism is still unclear.
To determine whether berberine could improve diabetes-associated cognitive dysfunction and to clarify the molecular pathways responsible for its actions, the research team conducted a controlled laboratory investigation using a mouse model. The researchers used streptozotocin to induce diabetes in mice. Berberine was administered to the animals both prior to and following the streptozotocin exposure for an overall intervention period of four weeks. The authors analyzed the impact of berberine on 4-hydroxy 2-nonenal adduct formation in diabetic mice and assessed the insulin signaling pathway to uncover the underlying molecular mechanism.
The molecular evaluations revealed that berberine treatment exerted pronounced positive effects on hippocampal insulin signaling pathways in the diabetic mice. Alongside the observed elevations in hippocampal insulin and insulin receptor concentrations, berberine therapy significantly increased the messenger RNA levels of key upstream and downstream signaling mediators, including phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), mammalian target of rapamycin (mTOR), and S6 kinase. The upregulation of these critical pathway components indicates that berberine stimulates the PI3K/AKT/mTOR signaling cascade, thereby helping to improve hippocampal insulin resistance in diabetic mice.
Quantitative analysis revealed that berberine treatment decreased BAD and NF-κB mRNA levels in the hippocampus of diabetic mice. Furthermore, berberine treatment decreased tau hyperphosphorylation in the hippocampus of diabetic mice.
The research team also observed that berberine treatment increased the messenger RNA levels of the cyclic AMP response element-binding protein (CREB) and CREB-binding protein (CBP) in the hippocampus of the diabetic mice, supporting a neuro-regenerative role for the intervention. The study authors concluded that berberine effectively improves hippocampal insulin resistance by activating the PI3K/AKT/mTOR pathway, curbing 4-HNE adduct formation, and decreasing tau hyperphosphorylation in diabetic mice. The authors stated that their study highlights a novel therapeutic target in diabetes-associated cognitive dysfunction and a new mechanism of action of berberine.
Subject of Research: Berberine and cognitive dysfunction in diabetic mice
Article Title: Berberine improves cognitive impairment in diabetic mice by mitigating 4-HNE-induced oxidative stress and enhancing hippocampal insulin sensitivity
Article References: Gupta, M., Rumman, M., Mahdi, A. A., & Pandey, S. (2026). Berberine improves cognitive impairment in diabetic mice by mitigating 4-HNE-induced oxidative stress and enhancing hippocampal insulin sensitivity. Molecular Biology Reports, 53(1), Article 1865. https://doi.org/10.1007/s11033-026-13042-9
Image Credits: AI Generated
DOI: 10.1007/s11033-026-13042-9
Keywords: berberine, diabetes, cognitive dysfunction, diabetic mice, hippocampus, insulin receptors, streptozotocin, 4-hydroxy 2-nonenal, PI3K, AKT, mTOR, S6 kinase, tau hyperphosphorylation, NF-κB, BAD, CREB, CBP, insulin resistance
News Source: Drew Townsend. (November 14, 2026). Berberine Improves Cognitive Function and Hippocampal Insulin Sensitivity in Diabetic Mice. Scienmag.



